Abiopharma

🔍 PARMAR KUSH (Executive)

Company: Entrada Therapeutics, Inc. (TRDA)

Report Date: 2026-07-30

Detailed Transactions and Holdings:

• Sold 114,756 shares of Common Stock at $6.93 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,848,310.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,718 shares of Common Stock at $6.85 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 2,846,592.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-30 | Code: H | nature_of_ownership: By 5AM Opportunities I, L.P. | shares_owned_after: 1,093,313.00 | Footnotes: F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.75 to $6.95 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F2: Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Kush M. Parmar, M.D., Ph.D. is a managing member of 5AM Partners and may be deemed to share voting and investment power over the shares held by 5AM V. Dr. Parmar disclaims beneficial ownership of the shares held by 5AM V except to the extent of his pecuniary interest therein.
• F3: Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Kush M. Parmar, M.D., Ph.D. is a managing member of Opportunities GP and may be deemed to share voting and investment power over the shares held by Opportunities. Dr. Parmar disclaims beneficial ownership of the shares held by Opportunities except to the extent of his pecuniary interest therein.